Ocular Therapeutix
OCUL
OCUL
68 hedge funds and large institutions have $88.6M invested in Ocular Therapeutix in 2019 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 26 increasing their positions, 19 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
0.52% less ownership
Funds ownership: 52.63% → 52.11% (-0.52%)
1% less funds holding
Funds holding: 69 → 68 (-1)
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
Holders
68
Holding in Top 10
3
Calls
$751K
Puts
$192K
Top Buyers
| 1 | +$7.54M | |
| 2 | +$2.13M | |
| 3 | +$1.92M | |
| 4 |
DAM
Deltec Asset Management
New York
|
+$397K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$278K |
Top Sellers
| 1 | -$5.48M | |
| 2 | -$3M | |
| 3 | -$837K | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$767K |
| 5 |
Morgan Stanley
New York
|
-$372K |